SEATTLE, Jan. 4 /PRNewswire/ -- The selection committee of Invest Northwest, a Washington Biotechnology & Biomedical Association (WBBA) event, extended invitations to 57 of the Pacific Northwest's most innovative public and private life science companies to present at Invest Northwest 2007, March 20 - 21, in Seattle.
Invest Northwest is a forum for senior executives from public and private life sciences companies to tell their stories to institutional investors, investment bankers, fund managers, venture capitalists, analysts, angel investors and prospective corporate partners from around the world.
The presenting companies for 2007 are:
Accium BioSciences Inc. Seattle, WA
Acrymed Inc. Beaverton, OR
Acucela Inc. Bothell, WA
Advanced Imaging Technologies Richland, WA
Alder Biotherapeutics Bothell, WA
Allon Therapeutics (TSX: NPC) Vancouver, BC
Amkor Pharma Sammamish, WA
Amnis Corporation Seattle, WA
Angiotech Pharmaceuticals(NASDAQ: ANPI; TSX: ANP) Vancouver, BC
Archus Orthopedics Inc. Redmond, WA
Biomira (NASDAQ: BIOM; TSX: BRA) Edmonton, AB
BioMS Medical Corporation (TSX: MS) Edmonton, AB
Calypso Medical Technologies Seattle, WA
Cardiac Science Corp. (NASDAQ: CSCX) Bothell, WA
Celator Pharmaceuticals Vancouver, BC
Cell Therapeutics (NASDAQ & MTAX: CTIC) Seattle, WA
Clera Inc. Vancouver, BC
CombiMatrix Corporation (NASDAQ: CBMX) Mukilteo, WA
Confirma Kirkland, WA
Dendreon Corporation (NASDAQ: DNDN) Seattle, WA
EGI Eugene, OR
enGene Inc. Vancouver, BC
Epigenomics AG (Frankfurt: ECX) Berlin, Germany
HemCon Medical Technologies Inc. Portland, OR
Ikaria Inc. Seattle, WA
Illumigen Biosciences Inc Seattle, WA
Inimex Pharmaceuticals Vancouver, BC
Koronis Pharmaceuticals Seattle, WA
Kryptiq Hillsboro, OR
LipoSonix Inc. Bothell, WA
MediQuest Therapeutics Bothell, WA
Nanostring Technologies Seattle, WA
Nastech Pharmaceutical Co (NASDAQ: NSTK) Bothell, WA
Neuromed Technologies Bothell, WA
Northstar Neuroscience Seattle, WA
Omeros Corp Seattle, WA
OncoGenex Technologies Vancouver, BC
Oncolytics Biotech Inc (TSX: ONC) Calgary, AB
Pathway Medical Technologies Redmond, WA
QLT Inc (NASDAQ: QLTI; TSX: QLT) Vancouver, BC
QuantRx Biomedical Corp Portland, OR
Response Biomedical Corporation (CDNX: RBM) Burnaby, BC
Rosetta Inpharmatics LLC Seattle, WA
SCOLR Pharma Inc Bellevue, WA
Seattle Genetics, Inc Bothell, WA
Second Act Partners Redmond, WA
SonoSite Inc (NASDAQ: SONO) Bothell, WA
Sonus Pharmaceuticals Inc (NASDAQ: SNUS) Bothell, WA
Sound Pharmaceuticals Inc Seattle, WA
Spaltudaq Corp Seattle, WA
Spiration, Inc Redmond, WA
Targeted Genetics Corporation (NASDAQ: TGEN) Seattle, WA
Targeted Growth Inc Seattle, WA
Trubion Pharmaceuticals (NASDAQ: TRBN) Seattle, WA
VLST Corp Seattle, WA
Xenon Pharmaceuticals Inc. Burnaby, BC
ZymoGenetics, Inc. (NASDAQ: ZGEN) Seattle, WA
Of the 57 presenting companies, 37 are from Washington State; 11 are from British Columbia; five are from Oregon and three are from Alberta. One company, Epigenomics, headquartered in Berlin, Germany, has a significant R & D presence in Washington State and is grandfathered into the conference. To qualify as a presenting company at Invest Northwest, a firm must be based in the Pacific Northwest and have the biosciences as its business base.
In addition to company presentations, the March 21- 22 forum will feature keynote speakers Ed Fritzky, founding member and former chairman, president and CEO of Immunex, and John Milligan, Executive VP and CFO, Gilead Sciences, plus industry panel discussions and a networking reception.
Members of the professional investment community and bioscience leaders are invited to register for Invest Northwest 2007 at http://www.washbio.org or call WBBA for information at (206) 624-1967.
Invest Northwest is produced by the Washington Biotechnology & Biomedical Association in collaboration with BC Biotech, BioAlberta, BioIdaho, Montana BioScience Alliance and the Oregon Bioscience Association.
Platinum Partner Sponsors of WBBA's Invest Northwest 2007 are
Kirkpatrick & Lockhart Preston Gates Ellis LLP and Moss Adams LLP.
Based in Seattle, the Washington Biotechnology & Biomedical Association (WBBA) is a not-for-profit association of Washington state-based biotechnology and medical device companies, research institutions and related organizations working together to extend better health to people everywhere. For more information about WBBA, visit www.wabio.com . To register for events, visit www.washbio.org .
For further information, contact:
Washington Biotechnology & Biomedical Association
Pam Love (206) 624-1967;
SOURCE Washington Biotechnology & Biomedical Association